Vikas Prasad, MD, PhD

Radiologist

Vikas Prasad

My Locations

Center for Advanced Medicine

Center for Advanced Medicine

On WashU Medicine Campus
4921 Parkview Place, Saint Louis, MO 63110

Expertise & Training

Video thumbnail for Vikas Prasad, MD, PhD

Watch video on YouTube

Vikas Prasad, MD, PhD

4 mins

Vikas Prasad, MD, PhD a Washington University Director of Clinical Theranostics and Professor of Radiology at Siteman Cancer Center, discusses his clinical specialty in radiopharmaceuticals.

Clinical Expertise

  • Nuclear Medicine

Primary Academic Title

Professor of Radiology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Director, Clinical Theranostics, WashU Medicine

Training

  • 2001 - 2003: Resident, Nuclear Medicine, Institute of Nuclear Medicine and Allies Sciences, Delhi, India
  • 2003 - 2005: Resident, Nuclear Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
  • 2006 - 2007: Clinical Research Associate, Nuclear Medicine, Zentralklinik Bad Berka, Germany
  • 2007 - 2009: Resident, Nuclear Medicine, Zentralklinik Bad Berka, Germany

Education

  • 2001: MBBS, Mahatma Gandhi Memorial Medical College, Indore, Devi Ahilya Vishwavidyalaya, India

Research & Selected Publications

Research Publications

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management
Authors:

Koumarianou A, Derks J, Tsoli M, one or more additional authors omitted Prasad V, one or more additional authors omitted Durand A

Journal & Year:

Endocr Rev | 2026

Advances in Molecular Imaging for Neuroendocrine Neoplasms
Authors:

Girod B, Prasad V

Journal & Year:

Cancers (Basel) | 2025

Theranostics in Lung Neuroendocrine Tumors
Authors:

Dev ID, Puranik AD, Trikalinos NA, one or more additional authors omitted Prasad V

Journal & Year:

Semin Nucl Med | 2025

Frontiers in radiopharmaceuticals for neuroendocrine tumors
Authors:

Puranik AD, Dev ID, Prasad V

Journal & Year:

J Neuroendocrinol | 2025

Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Me…
Authors:

Prasad V, Koumarianou A, Denecke T, one or more additional authors omitted Ambrosini V

Journal & Year:

J Neuroendocrinol | 2025

Asymmetric 18F-FDG Uptake in Oropharynx-PET Parameters to Minimize Unnecessary Interventions
Authors:

Prasad V, Parihar AS

Journal & Year:

JAMA Otolaryngol Head Neck Surg | 2024

Use of approved Lu-177 radiopharmaceuticals in patients with end-stage renal disease: A review of the literature and proposed treatment algorithm
Authors:

Trikalinos NA, Kim H, Vijayan A, Amurao M, Prasad V

Journal & Year:

J Neuroendocrinol | 2024

Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
Authors:

Ambrosini V, Caplin M, Castaño JP, one or more additional authors omitted Prasad V

Journal & Year:

J Neuroendocrinol | 2024